Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Youcare Pharmaceutical Group Co Days Payable Chart
SHSE:688658 vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, Youcare Pharmaceutical Group Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Youcare Pharmaceutical Group Co Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Youcare Pharmaceutical Group Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Youcare Pharmaceutical Group Co's Days Payable falls into.
Youcare Pharmaceutical Group Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Youcare Pharmaceutical Group Co (SHSE:688658) has a Days Payable of 230.06 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Youcare Pharmaceutical Group Co and its competitors. This is 22% above median its historical median of 188.91. Over the past decade, Youcare Pharmaceutical Group Co's Days Payable has ranged from 155.90 to 299.27. According to the industry distribution chart, Youcare Pharmaceutical Group Co ranks #279 out of 701 companies in the Biotechnology industry, placing it in the top 39.8%.
Is Youcare Pharmaceutical Group Co's Days Payable too high?
Youcare Pharmaceutical Group Co's current Days Payable of 230.06 is 22% above median its 10-year median of 188.91. Over the past 10 years, this metric has ranged from a low of 155.90 to a high of 299.27. The Biotechnology industry median Days Payable is 112.84. Youcare Pharmaceutical Group Co's value of 230.06 is 103.9% above this industry median. Based on the distribution chart, Youcare Pharmaceutical Group Co ranks #279 out of 701 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Youcare Pharmaceutical Group Co has a GF Score™ of 52/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Youcare Pharmaceutical Group Co's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Youcare Pharmaceutical Group Co ranks #279 out of 701 companies for Days Payable. This puts Youcare Pharmaceutical Group Co in the upper half of its industry. The industry median Days Payable is 112.84. Youcare Pharmaceutical Group Co's value of 230.06 is 103.9% above this benchmark. Historically, Youcare Pharmaceutical Group Co's own Days Payable has ranged from 155.90 to 299.27 over the past decade. While the company's 10-year median is 188.91 vs. the industry median of 112.84, Youcare Pharmaceutical Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 112.84, based on 701 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Youcare Pharmaceutical Group Co's current Days Payable of 230.06 is 103.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Youcare Pharmaceutical Group Co and its competitors. For the Biotechnology industry, the median Days Payable is 112.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Youcare Pharmaceutical Group Co's current Days Payable is 230.06, which is 22% above median its own 10-year median of 188.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Youcare Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Youcare Pharmaceutical Group Co (SHSE:688658) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥11.05, compared to a current price of ¥13.11 — trading 18.6% above its estimated fair value. The current Days Payable is 230.06, which is 22% above median its 10-year median of 188.91 and 103.9% above the Biotechnology industry median of 112.84. Youcare Pharmaceutical Group Co's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Youcare Pharmaceutical Group Co (SHSE:688658), the current Days Payable is 230.06 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Youcare Pharmaceutical Group Co (SHSE:688658) Overvalued in 2026?
Based on GuruFocus' analysis, Youcare Pharmaceutical Group Co stock appears to be overvalued.
The current stock price of ¥13.11 is trading 18.6% above its estimated GF Value™ of ¥11.05.
GuruFocus considers Youcare Pharmaceutical Group Co to be Modestly Overvalued.
Key valuation signals for SHSE:688658:
Days Payable: 230.06 (22% above median its 10-year median of 188.91)
GF Value™: ¥11.05 vs. price of ¥13.11 (18.6% above fair value)
Industry Position: 103.9% above the Biotechnology median (#279 of 701)
No single metric tells the full story. See the SHSE:688658 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Youcare Pharmaceutical Group Co Business Description
Youcare Pharmaceutical Group Co Ltd is a pharmaceutical group enterprise integrating new drug research and development, drug production, circulation and sales.
52GF Score
Get the complete analysis for SHSE:688658
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688658 has been successfully added to your 
